Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025 Pharmaceutical Investing
Faron Pharmaceuticals: FDA grants Fast Track Designation to Faron for Traumakine® Pharmaceutical Investing
Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER Pharmaceutical Investing
Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera Pharmaceutical Investing
